Evidence map›Paper›PMID 35475172›Full record

ArticleResearch square2022

Development of a Novel Human CD147 Knock-in NSG Mouse Model to Test SARS-CoV-2 Viral Infection.

Saiaditya Badeti, Qingkui Jiang, Alireza Naghizadeh, Hsiang-Chi Tseng, Yuri Bushkin, Salvatore A E Marras, Annuurun Nisa, Sanjay Tyagi, Fei Chen, Peter Romanienko and 8 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Saiaditya BadetiRutgers New Jersey Medical School.
Qingkui JiangRutgers New Jersey Medical School.
Alireza NaghizadehRutgers New Jersey Medical School.
Hsiang-Chi TsengRutgers New Jersey Medical School.
Yuri BushkinRutgers New Jersey Medical School.
Salvatore A E MarrasRutgers New Jersey Medical School.
Annuurun NisaRutgers New Jersey Medical School.
Sanjay TyagiRutgers New Jersey Medical School.
Fei ChenRutgers New Jersey Medical School.
Peter RomanienkoRutgers Cancer Institute of New Jersey.
Ghassan YehiaRutgers Cancer Institute of New Jersey.
Deborah EvansRutgers New Jersey Medical School.
Moises Lopez-GonzalezRutgers New Jersey Medical School.
David AllandRutgers New Jersey Medical School.
Riccardo RussoRutgers New Jersey Medical School.
William GauseRutgers New Jersey Medical School.
Lanbo ShiRutgers New Jersey Medical School.
Dongfang LiuRutgers New Jersey Medical School.ORCID 0000-0002-7295-8088
Rutgers, The State University of New Jersey · US

Funding

Rutgers Optimizes Innovation (ROI) ProgramU01HL150852 · NHLBI · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI LIBUTTI, STEVEN K., PANETTIERI, REYNOLD ALEXANDER · 2019 to 2022
$4.4M
The adaptor protein Crk in immune responsesR01AI130197 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Dongfang Liu · 2018 to 2026
$4.2M
Background free amplified single-molecule FISH for in situ and flow cytometric applicationsR01CA227291 · NCI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI TYAGI, SANJAY · 2018 to 2022
$2.8M
Leica TCS SP8 STED 3x super resolution microscope for the RBHS Newark campusS10OD025182 · OD · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LIU, DONGFANG · 2020 to 2020
$961k
The adaptor protein Crk in immune responsesR56AI130197 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI LIU, DONGFANG · 2017 to 2023
$874k
Program in Infection, Immunity and InflammationT32AI125185 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI SALGAME, PADMINI · 2016 to 2020
$747k
Bispecific cytotoxic lymphocytes in HIV-related lymphomaR21HL125018 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LIU, DONGFANG · 2015 to 2016
$449k
HIV-1-Specific CTL Exhaustion at Immune SynapseR21AI124769 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LIU, DONGFANG · 2016 to 2017
$446k
Targeting of Master Signaling Molecule to Restore Functions of Exhausted HIV-specific CTLsR21AI129594 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LIU, DONGFANG · 2017 to 2018
$438k
CD147-CAR-NK Cells for Hepatocellular Carcinoma TreatmentR21CA267368 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI LIU, DONGFANG · 2022 to 2023
$391k
NCI NIH HHS R01 CA227291NCI NIH HHS R21 CA267368NHLBI NIH HHS R21 HL125018NHLBI NIH HHS U01 HL150852NIAID NIH HHS R01 AI130197NIAID NIH HHS R21 AI124769NIAID NIH HHS R21 AI129594NIAID NIH HHS R56 AI130197NIAID NIH HHS T32 AI125185NIH HHS S10 OD025182
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35475172
PMCPMC9040682
OpenAlexW4224302190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.